Surrozen CFO acquires 607 company shares via plan
Surrozen, Inc. Chief Financial Officer Andrew Pedrum Maleki acquired 607 shares of Surrozen common stock on June 15, 2026.
Rhea-AI Filing Summary
Surrozen, Inc. Chief Financial Officer Andrew Pedrum Maleki acquired 607 shares of Surrozen common stock on June 15, 2026. The shares were obtained at a price of $19.01 per share under the Surrozen, Inc. 2021 Employee Stock Purchase Plan.
The filing notes this was a voluntary report of transactions that were exempt from short-swing profit rules under Rule 16b-3(d) and Rule 16b-3(c). Following this acquisition, Maleki directly holds 607 shares of Surrozen common stock.
Positive
- None.
Negative
- None.
Insights
Routine ESPP acquisition by CFO with a small share amount.
The transaction shows Surrozen’s CFO acquiring 607 shares of common stock at $19.01 per share via the 2021 Employee Stock Purchase Plan. The Form 4 classifies this as a grant or award-type acquisition, not an open-market purchase.
The footnote explains the transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c), indicating a board- or plan-approved mechanism rather than discretionary trading. With total holdings of 607 shares after the transaction and no derivative positions reported, this appears to be a modest, routine compensation-related equity purchase.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 607 | $19.01 | $12K |
Footnotes (1)
- F1. This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Key Figures
Key Terms
2021 Employee Stock Purchase Plan financial
Rule 16b-3(d) regulatory
Rule 16b-3(c) regulatory
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Surrozen (SRZN) CFO Andrew Pedrum Maleki report on this Form 4?
Was the Surrozen (SRZN) CFO transaction an open-market buy or a plan acquisition?
What is the role of Rule 16b-3 in this Surrozen (SRZN) insider transaction?
Does this Surrozen (SRZN) Form 4 show any option exercises or derivative securities?
AI-generated analysis. How Rhea-AI works. Not financial advice.